Feasibility of clinical dendritic cell vaccination in acute myeloid leukemia
- 14 September 2006
- journal article
- review article
- Published by Elsevier in Immunobiology
- Vol. 211 (6-8) , 677-685
- https://doi.org/10.1016/j.imbio.2006.05.013
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Breaking Tolerance to Tumors with Dendritic Cell-Based ImmunotherapyAnnals of the New York Academy of Sciences, 2005
- Employing the immunological synapse in AML: Development of leukemic dendritic cells for active specific immunizationImmunobiology, 2005
- Leukemia-derived dendritic cells in acute myeloid leukemia exhibit potent migratory capacityLeukemia, 2005
- Dendritic-cell-based therapeutic vaccination against cancerCurrent Opinion in Immunology, 2005
- Class II-Associated Invariant Chain Peptide Expression on Myeloid Leukemic Blasts Predicts Poor Clinical OutcomeCancer Research, 2004
- CD8 T-cell responses to Wilms tumor gene product WT1 and proteinase 3 in patients with acute myeloid leukemiaBlood, 2002
- Gene transfer of CD154 and IL12 cDNA induces an anti-leukemic immunity in a murine model of acute leukemiaLeukemia, 2002
- Generation of Dendritic Cells from Human Chronic Myelomonocytic Leukemia Cells in Fetal Calf Serum-Free MediumLeukemia & Lymphoma, 2000
- Human acute myeloblastic leukemia cells differentiatein vitro into mature dendritic cells and induce the differentiation of cytotoxic T cells against autologous leukemiasEuropean Journal of Immunology, 1999
- In Vitro Culture of Acute Myelogenous Leukemia Blasts: A Comparison of Four Different Culture MediaJournal of Hematotherapy, 1999